-
Product Insights
Unique Meghnaghat Combined Cycle Power Plant
Unique Meghnaghat Combined Cycle Power Plant is a thermal project located in Dhaka, Bangladesh. The project is owned by Nebras Power Investment Management BV; Strategic Finance Ltd; Unique Hotel and Resorts Ltd and is developed by Unique Meghnaghat Power Ltd. The project is currently under construction. Empower your strategies with our Unique Meghnaghat Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Analyst Opinions
NewLuxury Travel – Key Trends and Market Analysis by Destinations, Challenges and Opportunities, 2024 Update
Luxury Travel Market Report Overview The luxury travel market includes lodging, airlines, travel agencies, and destinations. The luxury travel industry is anticipated to benefit from the growing number of high-net-worth individuals as this will help tourists take advantage of and enjoy upmarket products and services on subsequent trips. Post the relaxation of COVID-19-induced travel restrictions, the luxury travel industry has reinforced its outlook and started prioritizing customer experiences rather than material belongings. In addition to embracing sustainability and responsible travel...
-
Product Insights
NewLikelihood of Approval Analysis for Lentivirus Infections
Overview How likely is it that the drugs in Lentivirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lentivirus Infections Overview Lentiviruses are a subgroup of retroviruses, a family of...
-
Product Insights
NewLikelihood of Approval Analysis for Refractory Chronic Lymphocytic Leukemia (CLL)
Overview How likely is it that the drugs in Refractory Chronic Lymphocytic Leukemia (CLL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Refractory Chronic Lymphocytic Leukemia (CLL) Overview Refractory chronic lymphocytic...
-
Sector Analysis
NewSecondhand Selling – Shopping Trends and Consumer Insights, 2024
Secondhand Selling Market Overview The secondhand market is constrained by concerns about the quality of secondhand goods, particularly, from consumers in Spain, Italy, and China. However, cost is one of the factors driving secondhand clothing & footwear buying, with more than 60% of consumers globally excluding China. China is majorly focusing on getting access to vintage, limited-edition, or unique items including all the other countries. Owing to this, Chinese consumers prefer items secondhand as they are more affordable. Buy the...
-
Company Insights
NewSwish – Competitor Profile
Swish is a Swedish mobile payment solution launched in 2012. It is one of the leading P2P payment solutions in Europe, with 8.4 million users. Initially launched as a P2P payment service, it was extended to allow merchants to accept payments for online and offline purchases. The solution enables users to make real-time P2P transfers from their smartphone using the recipient’s phone number or QR code. To transfer funds, both sender and recipient need to have a bank account with...
-
Thematic Analysis
NewPersonalization in Insurance – Thematic Intelligence
Personalization in Insurance Thematic Report Overview Insurance companies are recognizing the value of personalized policies to attract and retain customers. Insurers can personalize policies based on policyholder behaviors, preferences, and risk profiles, with unprecedented accuracy by leveraging AI and machine learning algorithms. Personalized policies not only provide customers with coverage that meets their specific requirements but also demonstrate an understanding of their unique circumstances, fostering trust and loyalty. The ‘Personalization in Insurance’ thematic intelligence report gives you an in-depth insight...
-
Analyst Opinions
NewWheels of Change – Startups Revolutionizing Mobility
Startups Revolutionizing Mobility Market Report Overview Technological innovations, evolving policies, and changing consumer preferences are driving the adoption of new mobility trends that are sustainable, smart, and flexible. The mobility sector is embracing advanced technologies and experiencing increased partnerships, investments, and government support. The ‘Wheels of Change: Startups Revolutionizing Mobility Market’ research provides valuable insights into innovative startups across 14 emerging trends in mobility. The report thoroughly examines the latest advancements, unique offerings, and venture capital activities of these startups,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Shylicine in Diarrhea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Shylicine in Diarrhea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Shylicine in Diarrhea Drug Details: Shylicine is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Glesatinib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Glesatinib in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glesatinib in Non-Small Cell Lung Cancer Drug Details: Glesatinib (MGCD-265)...